Statements, Letters, and Regulatory Comments

Cystic Fibrosis Foundation's COVID-19 Advocacy Efforts

Nothing is more important than the health and well-being of the cystic fibrosis community. The Cystic Fibrosis Foundation is actively engaged in efforts to ensure that both state and federal policies related to COVID-19 are in place to help people with CF and their loved ones through this difficult time. We will continue to monitor state and federal policy proposals and assess how they could affect the CF community.

Federal Activity

• April 1: Coalition statement urging the Administration to implement a special enrollment period for Healthcare.gov.
• March 30: Coalition letter to the U.S. Department of Health and Human Services (HHS) encouraging them to open a special enrollment period for the marketplace, provide subsidized COBRA coverage, and ensure coverage of COVID-19 testing and treatment.
• March 30: Coalition letter to the Administration asking to maintain social distancing practices and base any decision to relax them on medical evidence.
• March 23: Coalition letter to Congressional leadership asking for additional Medicaid funding to ensure states can mitigate the impact of COVID-19.
• March 20: Coalition letter to Congressional leadership requesting that they ensure all payers adhere to the Centers for Disease Control (CDC) recommendation for medication access and refills.

State Activity

• March 19: Coalition letter to governors calling for action on several policies crucial to mitigating the spread of COVID-19, including expanding access to telehealth services, and reducing barriers for testing and treatment.

CF Foundation's Ongoing Advocacy Efforts

2020 Federal Activity 

• March 23: CF Foundation comments on a Centers for Medicare and Medicaid Services (CMS) request for information on coordinating care for out-of-state providers for children with complex medical needs on the Medicaid program.
• March 12: Coalition letter to key U.S. House of Representatives Appropriations Subcommittees calling for increased funding for infection and antibiotic research and drug development.
• March 12: Coalition letter to key Senate Appropriations Subommittees calling for calling for increased funding for infection and antibiotic research and drug development programs in fiscal year 2021.
• March 9: CF Foundation comments to the U.S. Food and Drug Administration (FDA) on draft model guidance for demonstrating substantial evidence of effectiveness for human drug and biological products.
• March 9: Coalition comments to CMS opposing guidance encouraging states to adopt Medicaid block grants and per capita caps.
• March 2: CF Foundation comments to CMS regarding fiscal year 2021 changes to Notice of Benefit and Payment Parameters.
• March 2: Coalition comments to CMS regarding fiscal year 2021 changes to Notice of Benefit and Payment Parameters.
• February 12: Coalition statement on fiscal year 2021 funding recommendation for the National Institutes of Health (NIH).
• February 12: Coalition statement in response to the U.S. House Ways & Means Committee markup of legislation intended to prevent patients from facing surprise medical bills.
• February 11: CF Foundation comments to CMS in response to proposed changes to outcome measures and requirements for organ procurement organizations (OPO).
• February 11: CF Foundation comments to the Health Resources and Services Administration (HRSA) in response to proposed changes to remove financial disincentives for living organ donors.
• February 11: Coalition statement in response to the U.S. House Committee on Education and Labor's markup of legislation intended to prevent patients from facing surprise medical bills.
• January 31: Coalition comment letter to the CMS on the Medicaid Fiscal Accountability proposed rule.
• January 30: CF Foundation comment letter to the Social Security Administration on their draft rule regarding the frequency and notice of continuing disability rules.
• January 28: Coalition letter to U.S. Health and Human Services (HHS) Secretary Alex Azar urging the agency to take swift action to stabilize and strengthen the antibiotics market.
• January 21: Coalition statement expressing disappointment of the Supreme Court's decision not to expedite Texas v. United States.
• January 17: Coalition letter to HHS Secretary Alex Azar requesting a meeting to discuss concerns related to proposed changes to the Medicaid program.
• January 3: Coalition statement endorsing the expedited review of Texas v. United States.

2019 Federal Activity

• December 19: Coalition letter to HHS urging the department to ensure that the Advisory Committee on Heritable Disorders in Newborns and Children resumes its scheduled meetings while Congress continues its efforts to reauthorize the Newborn Screening Saves Lives Act.
• December 19: Coalition statement expressing disappointment in Fifth Circuit Court ruling in Texas v. United States.
• December 16: CF Foundation response letter to U.S. Reps. DeGette and Upton providing input on proposed Cures 2.0 legislative effort.
• December 13: Coalition letter urging the White House to continue pursuing legislation to protect patients and families from surprise medical billing.
• December 13: Coalition letter urging Congress to pass legislation to protect patients and families from surprise medical billing.
• December 4: Coalition letter to the U.S. Senate asking for co-sponsorship of bipartisan legislation that would make permanent the 7.5 percent threshold for medical expense tax deduction.
• December 4: Coalition letter to the U.S. House of Representative asking for co-sponsorship of bipartisan legislation that would make permanent the 7.5 percent threshold for medical expense tax deduction.
• November 21: Coalition letter to HHS encouraging the withdrawal of the “Insurance Standards Bulletin, Opportunity for States to Participate in a Wellness Program Demonstration Project to Implement Health-Contingent Wellness Programs in the Individual Market.”
• November 15: CF Foundation letter providing recommendations to the European Medicines Agency working group on pediatric clinical trial preparedness.
• November 12: Coalition letter to Congressional leadership asking Congress to pass comprehensive legislation to ban surprise medical billing by the end of 2019.
• November 11: Coalition letter to U.S. House of Representatives and U.S. Senate Appropriations Committees requesting continued support for programs that address antimicrobial resistance.
• November 11: Coalition letter to HHS encouraging the department to request new funding from Congress to combat antimicrobial resistance.
• October 30: Coalition statement supporting a Congressional Review Act resolution that would overturn CMS 1332 guidance permitting states to undermine Affordable Care Act patient protections.
• October 24: Coalition letter to U.S. House of Representatives and U.S. Senate Appropriations Committees encouraging quick enactment of a Labor-HHS-Education appropriations bill that provides robust funding for medical research.
• October 21: CF Foundation comments to the Institute for Clinical and Economic Review on their draft scoping document outlining their proposed analysis on highly effective modulator therapies.
• October 2: Coalition letter to Congressional leadership encouraging swift action on surprise medical billing.
• October 2: CF Foundation comments on United Network for Organ Sharing/Organ Procurement and Transplantation Network's continuous distribution of lungs concept paper.
• September 30: CF Foundation comments to the FDA on draft guidance for International Council for Harmonisation General Considerations for Clinical Studies.
• September 27: CF Foundation comments on CMS proposed rule on Medicare hospital outpatient and ambulatory surgical center payment systems.
• September 26: CF Foundation comments on CMS proposed rule on revisions to physician fee schedule and other changes to Medicare Part B payment policies.
• September 13: Coalition letter to CMS commenting on the Medicaid Access rule rescission.
• September 11: Coalition statement in response to the shift and uncertainty surrounding the medical deferred action program.
• August 19: Coalition statement on the Department of Homeland Security (DHS) opposing a proposed rule to include use of health care programs in the definition of “public charge” for non-citizens.
• August 6: CF Foundation comments on FDA draft guidance about enhancing the diversity of clinical trial populations.
• July 31: Coalition letter of support to Sen. Warner for S.J. Res 52, which would repeal the 1332 State Relief and Empowerment Waivers Guidance released in October 2018.
• July 24: Coalition letter of support to Reps. Neal, Brady, Pallone, and Walden, for their work to lower out-of-pocket costs under the current Medicare Part D benefit design.
• July 18: Coalition statement opposing Medicaid block grants.
• July 18: Coalition letter to CMS opposing Medicaid block grants.
• July 18: Coalition statement to Sens. Hassan and Gardner supporting the introduction of Newborn Screening Saves Lives Reauthorization Act of 2019.
• July 10: Coalition letter to the House Oversight and Reform Committee regarding Texas v. United States.
• July 8: Coalition letter to Sens. Casey and Isakson in support of the Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act.
• July 2: Coalition comments to HHS, CMS, and the Department of the Treasury regarding the Request for Information on 1332 State Relief and Empowerment Waiver guidance.
• June 24: Coalition letter to CMS regarding the proposed rule for fiscal year 2020 Medicare Hospital Inpatient Prospective Payment System.
• June 24: Coalition letter to Reps. Roybal-Allard, Simpson, Clark, and Herrera Beutler supporting the Newborn Screening Saves Lives Reauthorization Act of 2019.
• June 21: Coalition letter to Office of Management & Budget (OMB) opposing changes to the official poverty measure.
• June 18: Coalition letter to Congressional leadership opposing changes to the official poverty measure.
• June 18: CF Foundation letter to Rep. Castor supporting the designation of a national week of awareness for nontuberculous mycobacteria.
• June 17: CF Foundation letter to the FDA asking for a quick and efficient review of the triple-combination therapy, and to develop drug labeling to reflect the highly effective nature of the therapy.
• June 17: CF Foundation letter to Sen. Brown supporting the Family Coverage Act.
• June 6: CF Foundation letter to Reps. Neal and Brady, and Sens. Pallone and Walden on draft legislation aimed at improving Medicare Part D.
• June 5: CF Foundation letter to Sens. Alexander and Murray supporting the Alexander-Murray Health Care Costs Discussion draft.
• May 23: CF Foundation letter to Congressional leaders in support of robust funding for the NIH and FDA funding in fiscal year 2020.
• May 8: Coalition letter to Rep. Kuster in support of the Protecting Americans with Preexisting Conditions Act.
• May 8: Coalition letter to Reps. Pallone and Walden outlining the coalition's guiding principles that health care needs to be adequate, affordable, and accessible.
• May 6: Coalition letter to CMS responding to the Request for Information concerning the sale of individual health insurance coverage across state lines.
• April 24: CF Foundation letter to Rep. Kuster in support of the Protecting Americans with Preexisting Conditions Act.
• April 24: CF Foundation letter to Sen. Warner in support of the Protecting Americans with Preexisting Conditions Act.
• April 24: CF Foundation letter to Rep. Wild in support of the Family Health Care Affordability Act.
• April 24: CF Foundation letter to Rep. Craig in support of the State Health Care Premium Reduction Act of 2019.
• April 24: CF Foundation letter to Rep. Underwood in support of the Health Care Affordability Act of 2019.
• April 8: Coalition statement for the Record to the House Committee on Education and Labor supporting legislation to provide that the rule entitled “Short-Term, Limited Duration Insurance” shall have no force or effect. 
• April 2: CF Foundation comments to the U.S. Department of Agriculture on the Supplemental Nutrition Assistance Program proposed rule.
• April 1: Coalition provides amicus brief to the Fifth Circuit Court of the United States in support of the defendants in Texas v. United States.
• March 27: Coalition comments to HHS, CMS, Department of Labor (DOL), and the Internal Revenue Service (IRS) responding to the Request for Information regarding grandfathered group health plans and grandfathered group health insurance coverage.
• March 26: Coalition statement supporting the Protecting Pre-Existing Conditions and Making Healthcare More Affordable Act of 2019.
• March 20: Coalition letter requesting $41.6 billion in funding for the NIH for fiscal year 2020.
• March 12: Coalition letter to Reps. DeLauro, Cole, Bishop, Fortenberry, Lowey, and Rogers urging funding for research into causes antimicrobial resistance in fiscal year 2020.
• March 6: Coalition letter to HHS opposing work requirements for very low-income parents and caregivers who rely on Medicaid.
• March 1: Coalition letter to Sen. Alexander responding to Lowering Health Care Costs Request for Information.
• February 5: CF Foundation comments to FDA on framework for real-world evidence program.
• February 4: Coalition letter to Congress outlining the coalition's shared principles for 2019 reauthorization of the Newborn Screening Saves Lives Act.
• January 8: Coalition letter to HHS expressing concern about the Patient Protection and Affordable Care Act; Exchange Program Integrity rule.
• January 7: CF Foundation comments on HHS Request for Information on the draft National Action Plan for Combating Antibiotic-Resistant Bacteria.

2018 Federal Activity

• December 18: Coalition comments to HHS, CMS, and the Department of the Treasury opposing 1332 State Relief and Empowerment Waiver guidance.
• December 18: Coalition letter to HHS, CMS, and the Department of the Treasury opposing 1332 State Relief and Empowerment Waiver guidance.
• December 18: Coalition comments to DHS opposing a proposed rule to include use of health care programs in the definition of “public charge” for non-citizens.
• December 17: Coalition statement expressing concern regarding the district ruling in Texas v. United States.
• December 10: CF Foundation letter to Rep. Bill Foster supporting the Medical Records Access Fairness Act.
• November 30: CF Foundation comments to FDA on adaptive designs for clinical trials of drugs and biologics; draft guidance for industry.
• November 9: Coalition letter to D.C.'s Committee on Health supporting legislation to protect consumers from new harms and risks associated with short-term, limited-duration, and association health plans.
• October 10: CF Foundation comments to FDA on draft guidance on human gene therapy for rare diseases.
• October 3: CF Foundation comments to HHS on United Network for Organ Sharing/Organ Procurement and Transplantation Network proposal on framework for organ distribution.
• September 26: Coalition letter to HHS opposing step therapy in Medicare Advantage Plans.
• September 19: Coalition letter to Sen. Tillis expressing concern about provisions in the Ensuring Coverage for Patients with Pre-Existing Conditions Act.
• September 17: CF Foundation letter to Rep. Castor expressing support for a resolution opposing the short-term, limited-duration insurance plan rule.
• September 17: CF Foundation letter to Sen. Baldwin expressing support for a resolution opposing the short-term, limited-duration insurance plan rule.
• September 4: Coalition statement expressing concern about provisions in the Ensuring Coverage for Patients with Pre-Existing Conditions Act.
• August 22: Coalition letter to Sens. Roberts and Stabenow, and Reps. Conaway and Peterson, urging Congress to omit language from the final Farm Bill conference report related to association health plans.
• August 20: Coalition letter to the Senate Appropriations Committee requesting newborn screening activities funding in fiscal year 2019. 
• August 20: Coalition letter to the House of Representatives Appropriations Committee requesting newborn screening activities funding in fiscal year 2019. 
• August 1: Coalition statement opposing final short-term insurance plan rule.
• July 23: Coalition letter to HHS and CMS opposing decreased funding of CMS Navigator programs.
• July 16: Coalition letter to CMS opposing the decision to freeze risk-adjustment payments to insurers required under the Affordable Care Act.
• July 16: CF Foundation letter to HHS on American Patients First Drug Pricing Blueprint.
• July 11: Coalition statement opposing the decision of CMS to freeze risk-adjustment payments to insurers required under the Affordable Care Act.
• July 10: Coalition statement thanking the House and Senate Appropriation Committees for FDA funding in fiscal year 2019.
• June 19: Coalition statement expressing disappointment in the DOL's final rule on association health plans. 
• May 18: CF Foundation testimony on NIH, CDC, and Health Resources and Services Administration (HRSA) funding prepared for the Senate Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies.
• May 14: Coalition statement to CMS opposing Medicaid work requirements.
• April 25: CF Foundation testimony on NIH, CDC, and HRSA funding prepared for the House Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies.
• April 23: Coalition comments to HHS, U.S. Department of Treasury, and DOL, urging withdrawal of the short-term, limited-duration health plan proposed rule.
• April 23: Coalition letter to HHS, U.S. Department of Treasury, and DOL, urging withdrawal of the short-term, limited-duration health plan proposed rule.
• April 20: Coalition letter to Senate and House appropriators for their continued support of the Children's Hospitals Graduate Medical Education Program.
• April 17: Coalition letter to Congressional leadership expressing concern about the impact of the proposed rule on short-term, limited-duration plans.
• April 12: Coalition statement on the 2019 Notice of Benefit and Payment Parameters final rule.                                                  

2020 State Activity

• March 20: Coalition statement opposing Oklahoma's proposal to implement a Medicaid block grant and add barriers to access for those with complex conditions.
• March 3: CF Foundation comment letter to Kentucky's House of Representatives supporting legislation that would ban accumulator programs.
• March 2: Coalition letter to Missouri senator opposing legislation to add work and community engagement requirements as a condition of Medicaid eligibility.  
• February 21: CF Foundation letter to Missouri House and Senate asking members to oppose a proposed ballot initiative to add work and community engagement requirements as a condition of Medicaid eligibility.
• February 21: CF Foundation comments to New York's Medicaid Redesign Team asking for the preservation of funding for the Adult Cystic Fibrosis Assistance Program.
• February 12: CF Foundation letter to New York's Senate Finance Committee and Assembly Ways and Means Committee urging them to preserve funding for the Adult Cystic Fibrosis Assistance Program.
• February 7: CF Foundation comment letter to HHS opposing Georgia's proposal to partially expand Medicaid and add work requirements and premiums as conditions for enrollment. 
• January 17: CF Foundation letter to Mississippi's Medicaid director asking the state to revise its monthly prescription drug limit policy.
• January 17: CF Foundation comments to HHS asking the agency to deny Nebraska's request to eliminate Medicaid retroactive eligibility and establish tiered approach for expansion.

2019 State Activity

• December 23: CF Foundation comments to HHS opposing Tennessee's proposal to implement a Medicaid block grant and closed formulary.
• December 6: CF Foundation comments to Indiana supporting Medicaid expansion but expressing concern about work and community engagement requirements.
• December 6: CF Foundation comments to HHS opposing Utah's proposal to add premiums and eligibility restrictions to Medicaid.
• November 22: CF Foundation comments to HHS on Indiana's proposal to provide a bridge to commercial coverage for those who lose Medicaid eligibility based on income.
• November 21: CF Foundation letter to Texas Health and Human Services Commission requesting appropriation to help relieve the Children with Special Health Care Needs program waitlist.
• November 6: CF Foundation comments supporting Michigan's Department of Health and Human Services' update on Healthy Michigan Plans.
• October 31: Coalition comments to Louisiana's insurance commissioner supporting reinsurance and ACA patient protections.
• October 25: CF Foundation comments to Utah opposing the state's proposal to add premiums and eligibility restrictions to Medicaid.
• October 18: CF Foundation comments to Tennessee opposing the state's proposal to implement a Medicaid block grant and closed formulary.
• October 11: CF Foundation letter to Wisconsin's Medicaid director expressing concerns with the state's work and community engagement and premium requirements and asking the state to specifically and automatically exempt people with cystic fibrosis. 
• October 10: CF Foundation comments to HHS supporting Montana's request to extend Medicaid expansion but expressing concerns regarding the proposal to add work and community engagement requirements.
• September 30: CF Foundation letter supporting a Pennsylvania bill to ban accumulator programs in the state.
• September 19: CF Foundation comments opposing Idaho's proposal to implement work and community engagement requirements to its Medicaid program.
• August 23: CF Foundation letter thanking Ohio legislators for funding of Ohio's BCMH (Children with Medical Handicaps) program.
• August 22: CF Foundation letter to Montana HHS Director supporting the state's request to extend Medicaid expansion but expressing concerns regarding the proposal to add work and community engagement requirements and increase premiums.
• August 19: CF Foundation letter to Michigan Medicaid Director regarding cystic fibrosis transmembrane conductance regulator (CFTR) modulator coverage in Medicaid health plans.
• August 7: CF Foundation letter to HHS in support of New Mexico's proposal to remove barriers to care to the state's managed care program.
• August 2: Coalition letter to HHS in support of Iowa's proposal to extend Medicaid expansion and remove barriers to patient care.
• July 30: CF Foundation comments to HHS supporting the Montana's application to operate a reinsurance program.
• July 25: Coalition letter to the Tennessee Medicaid director and insurance commissioner opposing Medicaid block grants.
• July 10: Coalition comments to HHS opposing South Carolina's proposal to implement work and community engagement requirements in its Medicaid program.
• July 3: CF Foundation comments to HHS and Department of the Treasury supporting North Dakota's application to operate a reinsurance program.
• July 3: CF Foundation letter to HHS and Department of Treasury secretary in support of Colorado's application to operate a reinsurance program.
• June 30: CF Foundation letter to Idaho insurance commissioner commenting on Idaho's “Coverage Choice Waiver” application.
• June 28: CF Foundation comments to Utah Department of Health opposing Utah's application to institute Medicaid per capita caps.
• June 28: CF comments to Delaware insurance commissioner supporting Delaware's application to operate a reinsurance program.
• June 26: Coalition letter to all state insurance commissions on copay accumulator programs.
• June 21: CF Foundation letter to the New York Senate Help Committee supporting greater transparency in the pricing of prescription drugs.
• June 17: CF Foundation comments to Montana supporting the state's application to operate a reinsurance program.
• June 11: CF Foundation letter to Oregon Gov. Brown supporting greater transparency in prescription drug spending.
• June 7: CF Foundation letter to Maine House of Representatives supporting greater transparency in the pricing of prescription drugs.
• June 4: CF Foundation letter to Oregon Senate Committee on Health supporting greater transparency in the pricing of prescription drugs.
• June 4: CF Foundation letter to the New Hampshire House of Representatives supporting the ban of Medicaid work and community engagement requirements.
• May 28: Coalition letter to the Louisiana House of Representatives opposing inadequate protections for people with pre-existing conditions.
• May 28: CF Foundation letter asking Pennsylvania legislators to fully fund the Adult Cystic Fibrosis & Other Chronic Respiratory Illnesses program.
• May 7: CF Foundation letter to New Hampshire Senate Commerce Committee opposing the ban of manufacturer coupons.
• May 6: Coalition letter to the Alabama Senate opposing Medicaid work and community engagement requirements.
• May 6: CF Foundation comments to North Dakota insurance commissioner supporting the state's application to operate a reinsurance program.
• May 3: CF Foundation letter to Gov. DeSantis opposing short-term, limited-duration health plans.
• May 3: CF Foundation letter to Florida Gov. DeSantis in opposition to proposed changes to Medicaid retroactive eligibility.
• April 30: CF Foundation letter to Oklahoma Gov. Stitt supporting legislation that would allow students living with CF to self-administer pancreatic enzymes at school.
• April 2: Coalition letter to Tennessee General Assembly opposing Medicaid block grants.
• March 29: Coalition statement regarding the approval of Utah's proposal to partially expand the state's Medicaid program.
• March 28: Coalition statement supporting court ruling on Medicaid work and community engagement requirements and association health plans.
• March 22: CF Foundation comments to Idaho Medicaid director supporting state Medicaid expansion.
• March 11: CF Foundation letter to Florida House of Representatives opposing Medicaid work and community engagement requirements.
• March 4: Coalition letter to Virginia Gov. Northam opposing legislation that would destabilize the Virginia insurance market.
• February 8: Coalition comments to Mississippi Division of Medicaid providing input in the proposed Mississippi Medicaid Patient Advisory Council.
• January 22: CF Foundation comments to South Carolina HHS Director regarding the state's proposal to add work and community engagement requirements to its Medicaid program.

2018 State Activity

• November 21: Coalition letter to HHS asking to suspend Arkansas's work and community engagement requirements and halt implementation of similar requirements in other states.
• November 21: Coalition letter to D.C. Committee on Health supporting the restriction of association health plans and short-term, limited-duration plans.  
• October 26: CF Foundation comments to Tennessee's Medicaid director opposing Tennessee's proposal to institute Medicaid work and community engagement requirements.
• October 26: CF Foundation comments to HHS opposing Michigan's proposal to institute Medicaid work and community engagement requirements.
• October 3: CF Foundation letter to Arizona's Medicaid director asking for close monitoring of the transition from Arizona Health Care Cost Containment System to Complete Care.
• October 1: Coalition letter to HHS and CMS in supporting Maine's Medicaid expansion.
• August 29: CF Foundation comments to HHS opposing New Hampshire's proposal to implement work and community engagement requirements and eliminate retroactive eligibility for its Medicaid program.
• August 24: CF Foundation letter to Illinois Gov. Rauner supporting legislative efforts to stabilize the Illinois insurance marketplace.
• August 17: CF Foundation comments to HHS opposing Kentucky's proposal to institute Medicaid work and community engagement requirements.
• August 10: CF Foundation comments to Bureau of Medicaid Policy and Health System Innovation opposing Michigan's request to institute Medicaid work and community engagement requirements.
• August 10: CF Foundation comments to HHS and Department of the Treasury supporting New Jersey's application to operate a reinsurance program.
• August 9: Coalition comments to HHS and the Department of the Treasury supporting New Jersey's application to operate a reinsurance program.
• August 4: CF Foundation letter to HHS and Department of the Treasury supporting Maryland's request to operate a reinsurance program.
• August 3: Coalition comments to HHS and the Department of the Treasury supporting Maryland's Section 1332 State Relief and Innovation Waiver application to operate a reinsurance program.
• August 3: CF Foundation comments to HHS regarding Utah's 1115 Primary Care Network Demonstration Amendment: Adult Expansion Medicaid, supporting Medicaid expansion by opposing community engagement requirements.
• July 24: Coalition letter to CMS to ask for suspension of Kentucky's Medicaid work requirements.
• July 6: Coalition comments to HHS and CMS supporting Maine's 1332 State Relief and Innovation Waiver to implement a reinsurance program.
• July 6: CF Foundation comments to HHS and CMS supporting Maine's 1332 State Relief and Innovation Waiver to implement a reinsurance program.
• June 29: CF Foundation comments to New Jersey Department of Banking and Insurance supporting the state's 1332 State Relief and Innovation Waiver application to operate a reinsurance program.
• June 29: CF Foundation comments to New Hampshire HHS opposing Medicaid work requirements.
• June 26: Coalition comments to Washington insurance commissioner in support of regulating non-compliant health insurance plans, such as short-term plans.
• June 14: CF Foundation comments to HHS opposing Ohio's proposal to impose Medicaid work requirements.
• June 14: Coalition comments to the North Carolina General Assembly opposing health benefit plans.
• June 12: CF Foundation letter to the Pennsylvania Senate Health and Human Services Committee opposing Medicaid work requirements.
• June 8: Coalition comments to HHS and Department of the Treasury supporting Wisconsin's 1332 State Relief and Innovation Waiver to implement a reinsurance program.
• June 8: CF Foundation comments to HHS and the Department of the Treasury supporting Wisconsin's 1332 State Relief and Innovation Waiver to implement a reinsurance program.
• June 7: CF Foundation letter to Michigan Gov. Snyder opposing Medicaid work requirements.
• June 5: Coalition comments to HHS opposing Florida's request to eliminate Medicaid retroactive eligibility.
• June 5: CF Foundation letter to Michigan Gov. Snyder opposing Medicaid work requirements.
• May 3: CF Foundation letter to Colorado Senate Committee on Finance and Committee on Appropriations supporting infant newborn screening.
• May 2: CF Foundation comments to Michigan House Appropriations Committee opposing Medicaid work and community engagement requirements.
• April 27: CF Foundation comments to the Colorado Committee on State, Veteran & Military Affairs supporting infant newborn screening.  
• April 18: CF Foundation letter to Michigan Senate Competitiveness Committee and Gov. Snyder opposing Medicaid work and community engagement requirements.
• April 10: CF Foundation letter to Michigan Senate Competitiveness Committee opposing Medicaid work and community engagement requirements.
• April 4: CF Foundation letter to New Hampshire Gov. Sununu supporting Medicaid expansion but opposing work and community engagement requirements.
• April 4: CF Foundation letter to New Hampshire Speaker of the House Chandler supporting Medicaid expansion but opposing work and community engagement requirements.